Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.
Dr. Stephen Shrewsbury discusses the advances in medical technology. He also touches on the humble beginnings of medical discoveries.
Health Professional Radio
Neal Howard: Hello! You’re listening to Health Professional Radio. Thanks for being here. I’m your host Neal Howard. As far as medicine is concerned we have come quite a long way, especially in the just the past, well, 50 years, maybe even the last 20 years. We have seen medicine progress as far as technology is concerned, by leaps and bounds.
Our guest in studio today is Dr Steven Shrewsbury. He’s an author as well as a healthcare professional. He’s the author of Defy Your DNA, a book in which he outlines and describes a bit of technology known as “gene patches”. We’re dealing with illnesses and ailments on a genetic level, actually modifying strands of DNA. We’ll get into that today with Dr. Shrewsbury. How are you doing today, Steve?
Want to continue reading? Please log-in or register to see the Full Transcript.